Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells

Japanese Journal of Cancer Research

Volumn 90, Issue 7, 1999, Pages 781-787

  Nagasawa, Kazuki ^a   Fumihara, Tomohiko ^a   Ohnishi, Noriaki ^a   Yokoyama, Teruyoshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Anthracycline; Human leukemia HL60 cell; Human mononuclear cell; Nucleoside transport system; Transport mechanism

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE TRIPHOSPHATE; ANTHRACYCLINE; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; DAUNORUBICIN; DOXORUBICIN; IDARUBICIN; IONOPHORE; MONENSIN; SODIUM ION;

ARTICLE; CELL STRAIN HL 60; CELL TYPE; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; SODIUM CELL LEVEL;

EID: 0032811289     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00815.x     Document Type: Article

References (22)

1. Nagasawa, K., Natazuka, T., Chihara, K., Kitazawa, F., Tsumura, A., Takara, K., Nomiyama, M., Ohnishi, N. and Yokoyama, T. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells. Cancer Chemother. Pharmacol., 37, 297-304 (1996).
2. Nagasawa, K., Natazuka, T., Nomiyama, M., Ohnishi, N. and Yokoyama, T. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin. Biol. Pharm. Bull., 19, 100-105 (1996).
3. Nagasawa, K., Tsumura, A., Nomiyama, M., Ohnishi, N. and Yokoyama, T. Transport mechanism of pirarubicin in human mononuclear cells. Biol. Pharm. Bull., 19, 1203-1209 (1996).
4. Nagasawa, K., Ohnishi, N. and Yokoyama, T. Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs. Jpn. J. Cancer Res., 88, 750-759 (1997).
5. Nagasawa, K., Ohnishi, N. and Yokoyama, T. Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells. Jpn. J. Cancer Res., 89, 673-680 (1998).
6. Plagemann, P. G. W. and Wohlhueter, R. M. Permeation of nucleosides, nucleic acid bases, and nucleotides in animal cells. Curr. Top. Membr. Transp., 14, 225-330 (1980).
7. Plagemann, P. G. W., Wohlhueter, R. M. and Woffendin, C. Nucleoside and nucleobase transport in animal cells. Biochim. Biophys. Acta, 947, 405-443 (1988).
8. Griffith, D. A. and Jarvis, S. M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta, 1286, 153-181 (1996).
9. +-dependent nucleoside transporters. Pharm. Res., 14, 1524-1532 (1997).
10. Tarasiuk, J., Foucrier, J. and Garnier-Suillerot, A. Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukemic K562 cells. Biochem. Pharmacol., 45, 1801-1808 (1993).
11. Barcelo, F., Barcelo, I., Ferragut, F. A., Yanovich, S. and Gonzalez-Ros, J. M. Interaction of anthracyclines with nucleotides and related compounds studied by spectroscopy. Biochim. Biophys. Acta. 884, 172-181 (1986).
12. Crawford, C. R., Ng, C. Y. C., Noel, D. and Belt, J. A. Nucleoside transport in L1210 murine leukemia cells. J. Biol. Chem., 265, 9732-9736 (1990).
13. Cai, J. and Lee, C. W. Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells. Biochem. J., 320, 991-995 (1996).
14. Plagemann, P. G. W. and Woffendin, C. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine. Biochim. Biophys. Acta, 969, 1-8 (1988).
15. Dutcher, J. P., Wiernik, P. H., Markus, S., Weinberg, V., Schiffer, C. A. and Harwood, K. V. Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up. Leukemia, 7, 413-419 (1988).
16. Yates, J. W., Glidewell, O., Wiernik, P. H., Cooper, M. R., Steinberg, D., Dosik, H., Levy, R., Hoagland, C., Henry, P., Gottleib, A., Cornell, C., Berenberg, J., Hutchison, J. L., Raich, P., Nissen, N., Ellison, R. R., Frelick, R., James, G. W., Falkson, G., Silver, R. T., Haurani, F., Green, M., Henderson, E., Leone, L. and Holland, J. F. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood, 60, 454-462 (1982).
17. Van Sloten, K., Wiernik, P. H., Schiffer, C. A. and Schimpff, S. C. Evaluation of levamisole as an adjuvant to chemotherapy for treatment of ANLL. Cancer, 51, 1576-1580 (1983).
18. Yates, J. W., Wallace, H. R., Ellison, R. R. and Holland, J. F. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother. Rep., 57, 485-488 (1973).
19. Goh, L.-B., Mack, P. and Lee, C.-W. Nitrobenzylthioinosine-binding protein overexpression in human breast, liver, stomach and colorectal tumour tissues. Anticancer Res., 15, 2575-2580 (1995).
20. Deckert, J., Morgan, P. F. and Marangos, P. J. Adenosine uptake site heterogeneity in the mammalian CNS? Uptake inhibitors as probes and potential neuropharmaceuticals. Life Sci., 42, 1331-1345 (1988).
21. 3H]uridine influx studies. J. Neurochem., 59, 1363-1371 (1992).
22. 3H]nitrobenzylthioinosine binding site affinity in guinea pig kidney but not heart and brain. Life Sci., 59, 2051-2057 (1996).